Lisa Utzschneider Sells 12,448 Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS) Stock

Integral Ad Science Holding Corp. (NASDAQ:IASGet Free Report) CEO Lisa Utzschneider sold 12,448 shares of Integral Ad Science stock in a transaction on Tuesday, February 4th. The stock was sold at an average price of $10.61, for a total value of $132,073.28. Following the sale, the chief executive officer now owns 278,650 shares in the company, valued at $2,956,476.50. The trade was a 4.28 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Lisa Utzschneider also recently made the following trade(s):

  • On Tuesday, January 7th, Lisa Utzschneider sold 5,940 shares of Integral Ad Science stock. The stock was sold at an average price of $9.75, for a total transaction of $57,915.00.

Integral Ad Science Stock Up 0.3 %

IAS stock opened at $10.70 on Friday. Integral Ad Science Holding Corp. has a twelve month low of $7.98 and a twelve month high of $17.53. The firm has a market capitalization of $1.74 billion, a PE ratio of 53.50, a PEG ratio of 1.08 and a beta of 1.46. The company has a quick ratio of 3.71, a current ratio of 3.71 and a debt-to-equity ratio of 0.07. The stock has a 50-day simple moving average of $10.43 and a two-hundred day simple moving average of $10.84.

Integral Ad Science (NASDAQ:IASGet Free Report) last posted its earnings results on Tuesday, November 12th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The business had revenue of $133.50 million for the quarter, compared to analyst estimates of $138.06 million. During the same quarter in the prior year, the firm posted ($0.09) EPS. Integral Ad Science’s revenue was up 11.0% on a year-over-year basis. On average, equities analysts predict that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on IAS shares. Truist Financial reduced their target price on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Benchmark reissued a “hold” rating on shares of Integral Ad Science in a report on Thursday, November 14th. Piper Sandler lowered their target price on Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 13th. Scotiabank started coverage on Integral Ad Science in a research note on Thursday, December 5th. They set a “sector perform” rating and a $10.00 price target for the company. Finally, Oppenheimer lowered their price objective on Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 13th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, Integral Ad Science has a consensus rating of “Moderate Buy” and an average target price of $14.80.

Get Our Latest Stock Analysis on Integral Ad Science

Institutional Investors Weigh In On Integral Ad Science

A number of institutional investors and hedge funds have recently made changes to their positions in IAS. Bank of Montreal Can increased its stake in Integral Ad Science by 16.9% in the 2nd quarter. Bank of Montreal Can now owns 65,403 shares of the company’s stock worth $638,000 after acquiring an additional 9,476 shares during the last quarter. AQR Capital Management LLC increased its position in shares of Integral Ad Science by 167.4% in the second quarter. AQR Capital Management LLC now owns 34,685 shares of the company’s stock worth $337,000 after purchasing an additional 21,714 shares during the last quarter. The Manufacturers Life Insurance Company increased its position in shares of Integral Ad Science by 18.1% in the second quarter. The Manufacturers Life Insurance Company now owns 37,870 shares of the company’s stock worth $368,000 after purchasing an additional 5,806 shares during the last quarter. Essex Investment Management Co. LLC bought a new stake in Integral Ad Science during the third quarter valued at approximately $1,605,000. Finally, nVerses Capital LLC purchased a new position in Integral Ad Science in the 3rd quarter worth approximately $45,000. Hedge funds and other institutional investors own 95.78% of the company’s stock.

About Integral Ad Science

(Get Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Further Reading

Insider Buying and Selling by Quarter for Integral Ad Science (NASDAQ:IAS)

Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.